What researchers study
Melanotan II is a synthetic melanocortin receptor agonist studied for pigmentation, appetite signaling and sexual-function pathways. It is not FDA approved for tanning or general consumer use.
Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.
Potential side effects & unknowns
This compound deserves a stronger warning than most pages. FDA has cited published serious adverse-event reports involving Melanotan II, including melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism. Other reported effects include nausea, flushing and appetite changes.
Research highlight
Melanocortin agonism can increase pigmentation, which explains why Melanotan II attracted attention in tanning research. That pharmacologic effect is not the same as demonstrating safe cosmetic use, and serious safety concerns have been reported.
RESEARCH REFERENCE
Continue with the WILGO Research Library
The previously embedded third-party video is no longer available for off-site embedding. WILGO has removed it and retained the page's written research summary, references, and source information.
VIEW RESEARCH LIBRARYResearch references
FDA: safety risks for compounded Melanotan II ↗Looking for Melanotan II?
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.